Rank | Gene Set | Z-score |
---|---|---|
1 | proteasome assembly (GO:0043248) | 4.90012550 |
2 | ribosomal small subunit assembly (GO:0000028) | 4.75133117 |
3 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.66315047 |
4 | formation of translation preinitiation complex (GO:0001731) | 4.49549457 |
5 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.43827131 |
6 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.37488946 |
7 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.31987700 |
8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.31569137 |
9 | purine nucleobase biosynthetic process (GO:0009113) | 4.27304137 |
10 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.25490894 |
11 | maturation of SSU-rRNA (GO:0030490) | 4.25486768 |
12 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.23419969 |
13 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.21932066 |
14 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.19138811 |
15 | * negative regulation of ligase activity (GO:0051352) | 4.19138811 |
16 | respiratory electron transport chain (GO:0022904) | 4.16952165 |
17 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.14076651 |
18 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.14076651 |
19 | chaperone-mediated protein transport (GO:0072321) | 4.11865802 |
20 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.10983037 |
21 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.10983037 |
22 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.10983037 |
23 | electron transport chain (GO:0022900) | 4.09045886 |
24 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 4.06884982 |
25 | nucleobase biosynthetic process (GO:0046112) | 4.03045248 |
26 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.00430810 |
27 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.00430810 |
28 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.94575354 |
29 | cullin deneddylation (GO:0010388) | 3.91848562 |
30 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.86774267 |
31 | protein complex biogenesis (GO:0070271) | 3.86404506 |
32 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.77495275 |
33 | 7-methylguanosine mRNA capping (GO:0006370) | 3.77349901 |
34 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.76449808 |
35 | establishment of integrated proviral latency (GO:0075713) | 3.70604546 |
36 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.70510399 |
37 | NADH dehydrogenase complex assembly (GO:0010257) | 3.70510399 |
38 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.70510399 |
39 | 7-methylguanosine RNA capping (GO:0009452) | 3.70006298 |
40 | RNA capping (GO:0036260) | 3.70006298 |
41 | protein deneddylation (GO:0000338) | 3.69783098 |
42 | * positive regulation of ligase activity (GO:0051351) | 3.69579110 |
43 | ribosomal small subunit biogenesis (GO:0042274) | 3.68079280 |
44 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.67416727 |
45 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.67191872 |
46 | ribosomal large subunit biogenesis (GO:0042273) | 3.62528079 |
47 | ribosome biogenesis (GO:0042254) | 3.61514681 |
48 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.60713493 |
49 | DNA deamination (GO:0045006) | 3.60686483 |
50 | termination of RNA polymerase III transcription (GO:0006386) | 3.59679126 |
51 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.59679126 |
52 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.59626306 |
53 | rRNA modification (GO:0000154) | 3.58493409 |
54 | DNA strand elongation (GO:0022616) | 3.55815078 |
55 | respiratory chain complex IV assembly (GO:0008535) | 3.54090387 |
56 | regulation of mitochondrial translation (GO:0070129) | 3.52652569 |
57 | viral transcription (GO:0019083) | 3.51499439 |
58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.50568986 |
59 | translational termination (GO:0006415) | 3.50129170 |
60 | DNA replication checkpoint (GO:0000076) | 3.49217296 |
61 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.48808100 |
62 | CENP-A containing nucleosome assembly (GO:0034080) | 3.45030379 |
63 | ribosome assembly (GO:0042255) | 3.44619401 |
64 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.40828905 |
65 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.40828905 |
66 | telomere maintenance via recombination (GO:0000722) | 3.40169242 |
67 | oxidative phosphorylation (GO:0006119) | 3.37484589 |
68 | DNA replication initiation (GO:0006270) | 3.37285697 |
69 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.36860249 |
70 | * cell cycle G1/S phase transition (GO:0044843) | 3.35209448 |
71 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.35209448 |
72 | * positive regulation of cell cycle arrest (GO:0071158) | 3.35072317 |
73 | mitotic metaphase plate congression (GO:0007080) | 3.33931857 |
74 | DNA double-strand break processing (GO:0000729) | 3.33847875 |
75 | chromatin remodeling at centromere (GO:0031055) | 3.31185436 |
76 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.30714965 |
77 | translational initiation (GO:0006413) | 3.29393117 |
78 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.27745261 |
79 | cytochrome complex assembly (GO:0017004) | 3.27076533 |
80 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.26694748 |
81 | * regulation of ligase activity (GO:0051340) | 3.24662164 |
82 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.24434315 |
83 | establishment of viral latency (GO:0019043) | 3.24371168 |
84 | translation (GO:0006412) | 3.23483606 |
85 | protein neddylation (GO:0045116) | 3.22882563 |
86 | translational elongation (GO:0006414) | 3.22256931 |
87 | rRNA processing (GO:0006364) | 3.21888589 |
88 | spliceosomal snRNP assembly (GO:0000387) | 3.21817791 |
89 | cotranslational protein targeting to membrane (GO:0006613) | 3.19959300 |
90 | termination of RNA polymerase I transcription (GO:0006363) | 3.18346893 |
91 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.18134035 |
92 | ATP synthesis coupled proton transport (GO:0015986) | 3.17314698 |
93 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.17314698 |
94 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.17171766 |
95 | protein targeting to ER (GO:0045047) | 3.15261377 |
96 | mitotic recombination (GO:0006312) | 3.13409943 |
97 | transcription from RNA polymerase I promoter (GO:0006360) | 3.12003982 |
98 | * regulation of cellular amine metabolic process (GO:0033238) | 3.11573006 |
99 | protein localization to mitochondrion (GO:0070585) | 3.10225147 |
100 | cellular component biogenesis (GO:0044085) | 3.10190480 |
101 | rRNA metabolic process (GO:0016072) | 3.09093784 |
102 | rRNA methylation (GO:0031167) | 3.06039634 |
103 | establishment of protein localization to mitochondrion (GO:0072655) | 3.04162827 |
104 | maturation of 5.8S rRNA (GO:0000460) | 3.03709435 |
105 | protein localization to endoplasmic reticulum (GO:0070972) | 3.03453578 |
106 | DNA ligation (GO:0006266) | 3.02200928 |
107 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.01732860 |
108 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.00181001 |
109 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.98229289 |
110 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.96535459 |
111 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.96513494 |
112 | inner mitochondrial membrane organization (GO:0007007) | 2.92692209 |
113 | DNA damage response, detection of DNA damage (GO:0042769) | 2.92422614 |
114 | DNA replication-independent nucleosome organization (GO:0034724) | 2.91638412 |
115 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.91638412 |
116 | purine nucleotide salvage (GO:0032261) | 2.91148634 |
117 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.91008511 |
118 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.88872787 |
119 | * signal transduction in response to DNA damage (GO:0042770) | 2.86739296 |
120 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.86545424 |
121 | viral mRNA export from host cell nucleus (GO:0046784) | 2.86445395 |
122 | histone exchange (GO:0043486) | 2.86358013 |
123 | * negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.84278686 |
124 | * negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.84278686 |
125 | kinetochore assembly (GO:0051382) | 2.83673588 |
126 | pseudouridine synthesis (GO:0001522) | 2.83555667 |
127 | kinetochore organization (GO:0051383) | 2.83525251 |
128 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.83497607 |
129 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.82985818 |
130 | protein targeting to mitochondrion (GO:0006626) | 2.82644629 |
131 | * negative regulation of protein ubiquitination (GO:0031397) | 2.82124421 |
132 | viral life cycle (GO:0019058) | 2.81937645 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.91686604 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.21800971 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.12191516 |
4 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.97421724 |
5 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.81465291 |
6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.73061144 |
7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.56920977 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.37793912 |
9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.33365020 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.12411368 |
11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.00025261 |
12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.90754937 |
13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.90581428 |
14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.74644188 |
15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.72489943 |
16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.68498145 |
17 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.65303730 |
18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64668963 |
19 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.61499581 |
20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.56690758 |
21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.50202660 |
22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.45923799 |
23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40797520 |
24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.33301570 |
25 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.33232210 |
26 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.28789203 |
27 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.23057410 |
28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22908335 |
29 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.18162902 |
30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.08534177 |
31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08316867 |
32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.00773039 |
33 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.99000955 |
34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89861754 |
35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89824355 |
36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.89617298 |
37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.86665025 |
38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.84268449 |
39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79927502 |
40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.75319870 |
41 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73359637 |
42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71175281 |
43 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.69924354 |
44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.64555905 |
45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62428011 |
46 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60623411 |
47 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.59705435 |
48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58411708 |
49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.57599429 |
50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.47694046 |
51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47128537 |
52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43922561 |
53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40721780 |
54 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40446792 |
55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36246522 |
56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36233826 |
57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.35698986 |
58 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34080110 |
59 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32486565 |
60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31886671 |
61 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29375310 |
62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26875759 |
63 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21516940 |
64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19551372 |
65 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18174594 |
66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16446331 |
67 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16060501 |
68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14529252 |
69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13976471 |
70 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.13398793 |
71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10013767 |
72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09043101 |
73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07557909 |
74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05896891 |
75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05605730 |
76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05302253 |
77 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.02186676 |
78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00441187 |
79 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.99422836 |
80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98454677 |
81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97658622 |
82 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96504215 |
83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96334216 |
84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95698603 |
85 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92743442 |
86 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90560266 |
87 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90237697 |
88 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89440497 |
89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88441845 |
90 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.86835302 |
91 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.85312981 |
92 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.84661393 |
93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.83005122 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82269311 |
95 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80669694 |
96 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.79086114 |
97 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.78472239 |
98 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77754745 |
99 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.76522465 |
100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.76231745 |
101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.76041111 |
102 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75949800 |
103 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.75035810 |
104 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.74867136 |
105 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.74197628 |
106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.72571287 |
107 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.72448315 |
108 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.71991955 |
109 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.71460937 |
110 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.69815535 |
111 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.69610700 |
112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68849431 |
113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.66079297 |
114 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.65590779 |
115 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.65590779 |
116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64825437 |
117 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.64505019 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 5.23784519 |
2 | MP0004957_abnormal_blastocyst_morpholog | 3.97379795 |
3 | MP0010094_abnormal_chromosome_stability | 3.68257176 |
4 | MP0008057_abnormal_DNA_replication | 3.57055315 |
5 | MP0003077_abnormal_cell_cycle | 3.30490075 |
6 | MP0008058_abnormal_DNA_repair | 3.22209202 |
7 | MP0003111_abnormal_nucleus_morphology | 3.17734344 |
8 | MP0003186_abnormal_redox_activity | 2.72248408 |
9 | MP0001835_abnormal_antigen_presentation | 2.69201795 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.58698659 |
11 | MP0008007_abnormal_cellular_replicative | 2.54607331 |
12 | MP0004147_increased_porphyrin_level | 2.46334045 |
13 | MP0009785_altered_susceptibility_to | 2.41123828 |
14 | MP0002163_abnormal_gland_morphology | 2.39424768 |
15 | MP0008932_abnormal_embryonic_tissue | 2.32266954 |
16 | MP0003786_premature_aging | 2.27298833 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.25918493 |
18 | MP0003718_maternal_effect | 2.20926616 |
19 | MP0003195_calcinosis | 2.19238174 |
20 | MP0008877_abnormal_DNA_methylation | 2.15416535 |
21 | MP0009333_abnormal_splenocyte_physiolog | 2.03319881 |
22 | MP0005671_abnormal_response_to | 1.99273300 |
23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.96644033 |
24 | MP0001853_heart_inflammation | 1.80603052 |
25 | MP0000685_abnormal_immune_system | 1.78947790 |
26 | MP0001730_embryonic_growth_arrest | 1.71151683 |
27 | MP0006036_abnormal_mitochondrial_physio | 1.69034943 |
28 | MP0003123_paternal_imprinting | 1.64567909 |
29 | MP0002396_abnormal_hematopoietic_system | 1.63585750 |
30 | MP0000350_abnormal_cell_proliferation | 1.58363026 |
31 | MP0006035_abnormal_mitochondrial_morpho | 1.54648433 |
32 | MP0008260_abnormal_autophagy | 1.53579922 |
33 | MP0002102_abnormal_ear_morphology | 1.49802385 |
34 | MP0006072_abnormal_retinal_apoptosis | 1.49570081 |
35 | MP0005025_abnormal_response_to | 1.48936135 |
36 | MP0001545_abnormal_hematopoietic_system | 1.48115046 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.48115046 |
38 | MP0005000_abnormal_immune_tolerance | 1.45437807 |
39 | MP0009697_abnormal_copulation | 1.44750892 |
40 | MP0003950_abnormal_plasma_membrane | 1.43917362 |
41 | MP0003436_decreased_susceptibility_to | 1.40877585 |
42 | MP0005075_abnormal_melanosome_morpholog | 1.39118414 |
43 | MP0002837_dystrophic_cardiac_calcinosis | 1.38996078 |
44 | MP0005084_abnormal_gallbladder_morpholo | 1.37793548 |
45 | MP0002132_abnormal_respiratory_system | 1.35911918 |
46 | MP0002019_abnormal_tumor_incidence | 1.32704479 |
47 | MP0002138_abnormal_hepatobiliary_system | 1.31573967 |
48 | MP0002398_abnormal_bone_marrow | 1.30229004 |
49 | MP0002139_abnormal_hepatobiliary_system | 1.30168152 |
50 | MP0002452_abnormal_antigen_presenting | 1.29593443 |
51 | MP0000313_abnormal_cell_death | 1.29190494 |
52 | MP0002723_abnormal_immune_serum | 1.28842590 |
53 | MP0001819_abnormal_immune_cell | 1.26785651 |
54 | MP0002420_abnormal_adaptive_immunity | 1.24509605 |
55 | MP0009764_decreased_sensitivity_to | 1.24327079 |
56 | MP0000490_abnormal_crypts_of | 1.24167934 |
57 | MP0003724_increased_susceptibility_to | 1.23630075 |
58 | MP0001764_abnormal_homeostasis | 1.22772793 |
59 | MP0003763_abnormal_thymus_physiology | 1.22227682 |
60 | MP0001800_abnormal_humoral_immune | 1.21999688 |
61 | MP0006054_spinal_hemorrhage | 1.21580220 |
62 | MP0002938_white_spotting | 1.20105407 |
63 | MP0002419_abnormal_innate_immunity | 1.18280574 |
64 | MP0008872_abnormal_physiological_respon | 1.18120964 |
65 | MP0006292_abnormal_olfactory_placode | 1.17400411 |
66 | MP0001542_abnormal_bone_strength | 1.16778716 |
67 | MP0003011_delayed_dark_adaptation | 1.16186761 |
68 | MP0000716_abnormal_immune_system | 1.15579724 |
69 | MP0000689_abnormal_spleen_morphology | 1.15132437 |
70 | MP0002722_abnormal_immune_system | 1.14699151 |
71 | MP0002429_abnormal_blood_cell | 1.13207197 |
72 | MP0002006_tumorigenesis | 1.11870792 |
73 | MP0002210_abnormal_sex_determination | 1.11571419 |
74 | MP0000358_abnormal_cell_content/ | 1.10689563 |
75 | MP0003941_abnormal_skin_development | 1.08884705 |
76 | MP0005387_immune_system_phenotype | 1.06573802 |
77 | MP0001790_abnormal_immune_system | 1.06573802 |
78 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06303818 |
79 | MP0000372_irregular_coat_pigmentation | 1.06289893 |
80 | MP0006082_CNS_inflammation | 1.05126372 |
81 | MP0000858_altered_metastatic_potential | 1.04738209 |
82 | MP0010307_abnormal_tumor_latency | 1.04059701 |
83 | MP0002277_abnormal_respiratory_mucosa | 1.01993342 |
84 | MP0001697_abnormal_embryo_size | 1.01263539 |
85 | MP0005636_abnormal_mineral_homeostasis | 1.00954280 |
86 | MP0001529_abnormal_vocalization | 0.98898845 |
87 | MP0001727_abnormal_embryo_implantation | 0.98004549 |
88 | MP0004808_abnormal_hematopoietic_stem | 0.97781122 |
89 | MP0002080_prenatal_lethality | 0.97687729 |
90 | MP0001881_abnormal_mammary_gland | 0.97110625 |
91 | MP0009379_abnormal_foot_pigmentation | 0.96992713 |
92 | MP0008995_early_reproductive_senescence | 0.96188912 |
93 | MP0002736_abnormal_nociception_after | 0.95685523 |
94 | MP0005379_endocrine/exocrine_gland_phen | 0.95433525 |
95 | MP0005410_abnormal_fertilization | 0.94482565 |
96 | MP0001929_abnormal_gametogenesis | 0.94233331 |
97 | MP0002405_respiratory_system_inflammati | 0.93191056 |
98 | MP0002160_abnormal_reproductive_system | 0.92664092 |
99 | MP0001145_abnormal_male_reproductive | 0.92616725 |
100 | MP0008469_abnormal_protein_level | 0.92227050 |
101 | MP0005332_abnormal_amino_acid | 0.92190641 |
102 | MP0005380_embryogenesis_phenotype | 0.91168263 |
103 | MP0001672_abnormal_embryogenesis/_devel | 0.91168263 |
104 | MP0003890_abnormal_embryonic-extraembry | 0.89683830 |
105 | MP0005408_hypopigmentation | 0.89594286 |
106 | MP0001919_abnormal_reproductive_system | 0.89488726 |
107 | MP0001845_abnormal_inflammatory_respons | 0.88793721 |
108 | MP0005451_abnormal_body_composition | 0.88207296 |
109 | MP0005319_abnormal_enzyme/_coenzyme | 0.87829550 |
110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87654798 |
111 | MP0001293_anophthalmia | 0.86516704 |
112 | MP0005266_abnormal_metabolism | 0.86141717 |
113 | MP0010352_gastrointestinal_tract_polyps | 0.85537846 |
114 | MP0003984_embryonic_growth_retardation | 0.85461254 |
115 | MP0002166_altered_tumor_susceptibility | 0.84066265 |
116 | MP0008873_increased_physiological_sensi | 0.82391838 |
117 | MP0000703_abnormal_thymus_morphology | 0.81230925 |
118 | MP0002088_abnormal_embryonic_growth/wei | 0.80070685 |
119 | MP0002876_abnormal_thyroid_physiology | 0.77387382 |
120 | MP0001348_abnormal_lacrimal_gland | 0.77303046 |
121 | MP0005389_reproductive_system_phenotype | 0.77051206 |
122 | MP0001346_abnormal_lacrimal_gland | 0.76251806 |
123 | MP0003646_muscle_fatigue | 0.76145934 |
124 | MP0004782_abnormal_surfactant_physiolog | 0.75568688 |
125 | MP0000653_abnormal_sex_gland | 0.74987104 |
126 | MP0003315_abnormal_perineum_morphology | 0.74464076 |
127 | MP0002090_abnormal_vision | 0.73648590 |
128 | MP0005365_abnormal_bile_salt | 0.73548957 |
129 | MP0001119_abnormal_female_reproductive | 0.73138569 |
130 | MP0003448_altered_tumor_morphology | 0.72491290 |
131 | MP0003121_genomic_imprinting | 0.72154406 |
132 | MP0004215_abnormal_myocardial_fiber | 0.70280999 |
133 | MP0002254_reproductive_system_inflammat | 0.69833493 |
134 | MP0001666_abnormal_nutrient_absorption | 0.69338726 |
135 | MP0001873_stomach_inflammation | 0.69137884 |
136 | MP0001905_abnormal_dopamine_level | 0.68558340 |
137 | MP0005085_abnormal_gallbladder_physiolo | 0.68005116 |
138 | MP0008789_abnormal_olfactory_epithelium | 0.67825974 |
139 | MP0003252_abnormal_bile_duct | 0.67301787 |
140 | MP0005165_increased_susceptibility_to | 0.66851340 |
141 | MP0005395_other_phenotype | 0.66065475 |
142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65580684 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Birth length less than 3rd percentile (HP:0003561) | 4.36983685 |
2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.28692860 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 4.04708025 |
4 | Acute necrotizing encephalopathy (HP:0006965) | 4.00597219 |
5 | Reticulocytopenia (HP:0001896) | 3.74520665 |
6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.69941995 |
7 | Mitochondrial inheritance (HP:0001427) | 3.62943550 |
8 | Increased CSF lactate (HP:0002490) | 3.49709373 |
9 | Breast hypoplasia (HP:0003187) | 3.43509239 |
10 | Abnormality of glycolysis (HP:0004366) | 3.28548515 |
11 | Increased serum pyruvate (HP:0003542) | 3.28548515 |
12 | Hepatocellular necrosis (HP:0001404) | 3.25608006 |
13 | Acute encephalopathy (HP:0006846) | 3.19529519 |
14 | Progressive macrocephaly (HP:0004481) | 3.17342235 |
15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.12090199 |
16 | Hepatic necrosis (HP:0002605) | 3.10308041 |
17 | Cerebral hypomyelination (HP:0006808) | 3.07357196 |
18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.05954063 |
19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.05954063 |
20 | Carpal bone hypoplasia (HP:0001498) | 3.03606064 |
21 | Abnormality of the anterior horn cell (HP:0006802) | 3.03587596 |
22 | Degeneration of anterior horn cells (HP:0002398) | 3.03587596 |
23 | Oral leukoplakia (HP:0002745) | 3.02596104 |
24 | Aplastic anemia (HP:0001915) | 2.99779779 |
25 | Increased serum lactate (HP:0002151) | 2.96671285 |
26 | Microvesicular hepatic steatosis (HP:0001414) | 2.91624079 |
27 | 3-Methylglutaconic aciduria (HP:0003535) | 2.85197854 |
28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.84929723 |
29 | Multiple enchondromatosis (HP:0005701) | 2.82611200 |
30 | Macrocytic anemia (HP:0001972) | 2.79482123 |
31 | Rough bone trabeculation (HP:0100670) | 2.77754340 |
32 | Lipid accumulation in hepatocytes (HP:0006561) | 2.77578602 |
33 | Increased IgM level (HP:0003496) | 2.71311267 |
34 | Optic disc pallor (HP:0000543) | 2.70280034 |
35 | Exertional dyspnea (HP:0002875) | 2.69224972 |
36 | Lethargy (HP:0001254) | 2.69170632 |
37 | Generalized aminoaciduria (HP:0002909) | 2.65659491 |
38 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.60448152 |
39 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.58698343 |
40 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.58698343 |
41 | Abnormal protein glycosylation (HP:0012346) | 2.58698343 |
42 | Abnormal glycosylation (HP:0012345) | 2.58698343 |
43 | Exercise intolerance (HP:0003546) | 2.55353562 |
44 | Pallor (HP:0000980) | 2.53162994 |
45 | Abnormality of methionine metabolism (HP:0010901) | 2.50603154 |
46 | B lymphocytopenia (HP:0010976) | 2.47828868 |
47 | Respiratory difficulties (HP:0002880) | 2.46599500 |
48 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.46271509 |
49 | Abnormality of B cell number (HP:0010975) | 2.45642865 |
50 | Cleft eyelid (HP:0000625) | 2.42803259 |
51 | Microretrognathia (HP:0000308) | 2.42492911 |
52 | Type I transferrin isoform profile (HP:0003642) | 2.40503986 |
53 | Lactic acidosis (HP:0003128) | 2.37826101 |
54 | Poor head control (HP:0002421) | 2.37248232 |
55 | Respiratory failure (HP:0002878) | 2.35228749 |
56 | Patellar aplasia (HP:0006443) | 2.34682557 |
57 | Renal Fanconi syndrome (HP:0001994) | 2.33182477 |
58 | Abnormal spermatogenesis (HP:0008669) | 2.31960706 |
59 | Trismus (HP:0000211) | 2.31521948 |
60 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.30537757 |
61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.29055702 |
62 | Methylmalonic aciduria (HP:0012120) | 2.28901745 |
63 | Cerebral edema (HP:0002181) | 2.26408522 |
64 | Type 2 muscle fiber atrophy (HP:0003554) | 2.24435161 |
65 | Impulsivity (HP:0100710) | 2.22814102 |
66 | Methylmalonic acidemia (HP:0002912) | 2.22013299 |
67 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.21737016 |
68 | Colon cancer (HP:0003003) | 2.21089470 |
69 | Muscle fiber atrophy (HP:0100295) | 2.18955243 |
70 | Secondary amenorrhea (HP:0000869) | 2.18392693 |
71 | Abnormal trabecular bone morphology (HP:0100671) | 2.17452113 |
72 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15935166 |
73 | Abnormality of serum amino acid levels (HP:0003112) | 2.13179406 |
74 | Meckel diverticulum (HP:0002245) | 2.12502886 |
75 | Abnormality of renal resorption (HP:0011038) | 2.11070551 |
76 | CNS demyelination (HP:0007305) | 2.10613830 |
77 | Recurrent abscess formation (HP:0002722) | 2.10452056 |
78 | Abnormality of the preputium (HP:0100587) | 2.09847769 |
79 | Sparse eyelashes (HP:0000653) | 2.09516786 |
80 | Amniotic constriction ring (HP:0009775) | 2.09493668 |
81 | Abnormality of placental membranes (HP:0011409) | 2.09493668 |
82 | Chromsome breakage (HP:0040012) | 2.08235655 |
83 | Absent thumb (HP:0009777) | 2.08211254 |
84 | Pancytopenia (HP:0001876) | 2.05733715 |
85 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.04484258 |
86 | Granulocytopenia (HP:0001913) | 2.04393249 |
87 | Agnosia (HP:0010524) | 2.04273900 |
88 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.04240846 |
89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.00696841 |
90 | Abnormality of alanine metabolism (HP:0010916) | 2.00696841 |
91 | Hyperalaninemia (HP:0003348) | 2.00696841 |
92 | Reduced antithrombin III activity (HP:0001976) | 2.00527706 |
93 | Glossoptosis (HP:0000162) | 1.99913097 |
94 | Glycosuria (HP:0003076) | 1.99374383 |
95 | Abnormality of urine glucose concentration (HP:0011016) | 1.99374383 |
96 | Bone marrow hypocellularity (HP:0005528) | 1.98577568 |
97 | Cellular immunodeficiency (HP:0005374) | 1.98114223 |
98 | Abnormality of the ileum (HP:0001549) | 1.97788783 |
99 | Prolonged neonatal jaundice (HP:0006579) | 1.97233486 |
100 | CNS hypomyelination (HP:0003429) | 1.97091171 |
101 | Thrombocytosis (HP:0001894) | 1.96997722 |
102 | IgG deficiency (HP:0004315) | 1.95546067 |
103 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.95080057 |
104 | Nausea (HP:0002018) | 1.93926138 |
105 | Premature graying of hair (HP:0002216) | 1.93183576 |
106 | Emotional lability (HP:0000712) | 1.91688693 |
107 | X-linked dominant inheritance (HP:0001423) | 1.91167789 |
108 | Leukodystrophy (HP:0002415) | 1.91123188 |
109 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.88499322 |
110 | Abnormality of chromosome stability (HP:0003220) | 1.88128386 |
111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87501254 |
112 | Irregular epiphyses (HP:0010582) | 1.86354678 |
113 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.85295107 |
114 | Increased muscle lipid content (HP:0009058) | 1.85069505 |
115 | Postnatal microcephaly (HP:0005484) | 1.84641839 |
116 | Stenosis of the external auditory canal (HP:0000402) | 1.82727723 |
117 | Abnormality of the pons (HP:0007361) | 1.82484767 |
118 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82003918 |
119 | Dicarboxylic aciduria (HP:0003215) | 1.82003918 |
120 | Recurrent bacterial skin infections (HP:0005406) | 1.81989244 |
121 | Duodenal stenosis (HP:0100867) | 1.81448855 |
122 | Small intestinal stenosis (HP:0012848) | 1.81448855 |
123 | Absent radius (HP:0003974) | 1.81082658 |
124 | Testicular atrophy (HP:0000029) | 1.80748858 |
125 | Selective tooth agenesis (HP:0001592) | 1.79947483 |
126 | Premature ovarian failure (HP:0008209) | 1.78990592 |
127 | Autoimmune thrombocytopenia (HP:0001973) | 1.78551433 |
128 | Congenital, generalized hypertrichosis (HP:0004540) | 1.78420771 |
129 | Petechiae (HP:0000967) | 1.78091210 |
130 | Eosinophilia (HP:0001880) | 1.77656195 |
131 | Palpitations (HP:0001962) | 1.76361299 |
132 | Hypothermia (HP:0002045) | 1.75137531 |
133 | Blindness (HP:0000618) | 1.72742971 |
134 | Posterior subcapsular cataract (HP:0007787) | 1.71513351 |
135 | Combined immunodeficiency (HP:0005387) | 1.70468187 |
136 | Neoplasm of the adrenal gland (HP:0100631) | 1.69028138 |
137 | Hypoplasia of the pons (HP:0012110) | 1.68694241 |
138 | Delayed CNS myelination (HP:0002188) | 1.66914637 |
139 | Pancreatic cysts (HP:0001737) | 1.66896797 |
140 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.65170006 |
141 | Myelodysplasia (HP:0002863) | 1.63764738 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 4.66287712 |
2 | EIF2AK1 | 4.07011447 |
3 | VRK2 | 4.01816466 |
4 | WEE1 | 3.79664165 |
5 | NME2 | 3.56453300 |
6 | STK16 | 3.13865037 |
7 | EIF2AK3 | 2.91326462 |
8 | PBK | 2.70944348 |
9 | SRPK1 | 2.45940243 |
10 | ACVR1B | 2.32699189 |
11 | PIM2 | 2.18696601 |
12 | PLK4 | 2.13478563 |
13 | CDC7 | 2.08874005 |
14 | TSSK6 | 2.08673940 |
15 | MST4 | 2.07156517 |
16 | VRK1 | 1.89811876 |
17 | BRSK2 | 1.87388078 |
18 | NEK1 | 1.83598697 |
19 | TESK1 | 1.80690946 |
20 | TRIM28 | 1.75613347 |
21 | MKNK1 | 1.51315704 |
22 | ARAF | 1.49370379 |
23 | TESK2 | 1.46926051 |
24 | PLK1 | 1.44097013 |
25 | PLK3 | 1.42597556 |
26 | NME1 | 1.33675789 |
27 | EIF2AK2 | 1.29925306 |
28 | SCYL2 | 1.28360625 |
29 | NEK2 | 1.26053245 |
30 | MAP3K14 | 1.25354812 |
31 | BCR | 1.24297661 |
32 | PDK4 | 1.22657573 |
33 | PDK3 | 1.22657573 |
34 | TAF1 | 1.22459566 |
35 | MAP4K2 | 1.22274153 |
36 | DYRK3 | 1.20529542 |
37 | ZAK | 1.19339354 |
38 | IRAK4 | 1.12267659 |
39 | KDR | 1.12240605 |
40 | ADRBK2 | 1.12115041 |
41 | WNK3 | 1.10792911 |
42 | AURKB | 1.10300836 |
43 | BRAF | 1.09361323 |
44 | LIMK1 | 1.06669819 |
45 | BRSK1 | 1.05506196 |
46 | TTK | 1.02466506 |
47 | RPS6KA4 | 1.01028841 |
48 | AURKA | 0.99945910 |
49 | DAPK1 | 0.97384713 |
50 | CCNB1 | 0.95286358 |
51 | PDK2 | 0.95261264 |
52 | PASK | 0.94556422 |
53 | ABL2 | 0.94218589 |
54 | ATR | 0.89908269 |
55 | FLT3 | 0.87881165 |
56 | MKNK2 | 0.87632160 |
57 | CSNK1G3 | 0.87425916 |
58 | IKBKB | 0.87185453 |
59 | STK4 | 0.86636271 |
60 | PIM1 | 0.80841642 |
61 | CDK7 | 0.80250376 |
62 | TGFBR1 | 0.80172810 |
63 | MAP3K12 | 0.79084298 |
64 | IRAK3 | 0.77997613 |
65 | CSNK2A1 | 0.76208816 |
66 | PLK2 | 0.74052376 |
67 | JAK3 | 0.73301333 |
68 | RPS6KB2 | 0.72411257 |
69 | STK24 | 0.72108637 |
70 | BCKDK | 0.71191828 |
71 | ERBB4 | 0.70933404 |
72 | CHEK2 | 0.70573156 |
73 | CSNK1G1 | 0.69925086 |
74 | EPHA2 | 0.69396576 |
75 | GRK1 | 0.69341601 |
76 | TLK1 | 0.69337761 |
77 | TYK2 | 0.69181468 |
78 | MST1R | 0.68472968 |
79 | PAK1 | 0.68187711 |
80 | DYRK2 | 0.67924575 |
81 | CDK4 | 0.67633835 |
82 | MAP3K8 | 0.67609395 |
83 | TBK1 | 0.67374121 |
84 | CSNK2A2 | 0.62704067 |
85 | CSNK1G2 | 0.61151910 |
86 | PAK4 | 0.59701505 |
87 | CSNK1A1L | 0.59540966 |
88 | BLK | 0.58853925 |
89 | GRK7 | 0.57236319 |
90 | BMPR2 | 0.55637655 |
91 | CHEK1 | 0.55154694 |
92 | TXK | 0.55109063 |
93 | KIT | 0.55023455 |
94 | CDK8 | 0.54402883 |
95 | MAPKAPK5 | 0.54398317 |
96 | ILK | 0.54074252 |
97 | TEC | 0.52801213 |
98 | OXSR1 | 0.52678916 |
99 | MAP3K11 | 0.51939891 |
100 | MYLK | 0.51545754 |
101 | AKT3 | 0.50881408 |
102 | NUAK1 | 0.50014090 |
103 | ERBB3 | 0.49450262 |
104 | NEK9 | 0.49336630 |
105 | SYK | 0.48338573 |
106 | YES1 | 0.45687877 |
107 | ATM | 0.43373756 |
108 | WNK4 | 0.43024669 |
109 | BMPR1B | 0.42439118 |
110 | STK38L | 0.42312369 |
111 | OBSCN | 0.41750483 |
112 | INSRR | 0.41359508 |
113 | DAPK3 | 0.41341924 |
114 | CLK1 | 0.41247095 |
115 | RPS6KA5 | 0.41078873 |
116 | PNCK | 0.40744003 |
117 | STK39 | 0.39344640 |
118 | BTK | 0.39034644 |
119 | MAP2K7 | 0.38710408 |
120 | MAPKAPK3 | 0.37942700 |
121 | TAOK3 | 0.37901199 |
122 | ZAP70 | 0.37589368 |
123 | STK10 | 0.36987168 |
124 | ALK | 0.36889146 |
125 | SIK3 | 0.35127195 |
126 | LYN | 0.34746422 |
127 | LRRK2 | 0.33706040 |
128 | NLK | 0.33655268 |
129 | CHUK | 0.32433143 |
130 | PRKCI | 0.31335607 |
131 | MATK | 0.27989349 |
132 | CSNK1A1 | 0.27188835 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Proteasome_Homo sapiens_hsa03050 | 5.59491834 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.80835272 |
3 | RNA polymerase_Homo sapiens_hsa03020 | 3.65678891 |
4 | DNA replication_Homo sapiens_hsa03030 | 3.62020551 |
5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.25815298 |
6 | Mismatch repair_Homo sapiens_hsa03430 | 2.97788679 |
7 | Spliceosome_Homo sapiens_hsa03040 | 2.60849560 |
8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.51658272 |
9 | RNA transport_Homo sapiens_hsa03013 | 2.38286786 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.33471412 |
11 | Homologous recombination_Homo sapiens_hsa03440 | 2.25715524 |
12 | Base excision repair_Homo sapiens_hsa03410 | 2.16223426 |
13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.14264852 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.06144505 |
15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.04453883 |
16 | Basal transcription factors_Homo sapiens_hsa03022 | 1.87554647 |
17 | Protein export_Homo sapiens_hsa03060 | 1.82792641 |
18 | Allograft rejection_Homo sapiens_hsa05330 | 1.79038625 |
19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65903392 |
20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.65885812 |
21 | Cell cycle_Homo sapiens_hsa04110 | 1.65020645 |
22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.64956583 |
23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55034279 |
24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49388201 |
25 | Purine metabolism_Homo sapiens_hsa00230 | 1.40121394 |
26 | RNA degradation_Homo sapiens_hsa03018 | 1.37031175 |
27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33741976 |
28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26971735 |
29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26585114 |
30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.26368682 |
31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22486711 |
32 | Legionellosis_Homo sapiens_hsa05134 | 1.19833205 |
33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.18325960 |
34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14688991 |
35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12680394 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11414878 |
37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09227344 |
38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08354984 |
39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02237959 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01979164 |
41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01841651 |
42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01685298 |
43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00837585 |
44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94796059 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94106254 |
46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93899304 |
47 | Peroxisome_Homo sapiens_hsa04146 | 0.91744300 |
48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91554686 |
49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90173502 |
50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90087930 |
51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90046619 |
52 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.84200330 |
53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81544549 |
54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81142296 |
55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80111279 |
56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71111264 |
57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68764386 |
58 | Asthma_Homo sapiens_hsa05310 | 0.68152711 |
59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67146301 |
60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65699714 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64421106 |
62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63043431 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60544018 |
64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60212074 |
65 | Measles_Homo sapiens_hsa05162 | 0.59280634 |
66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58873318 |
67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56984774 |
68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56712484 |
69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55287705 |
70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53678728 |
71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53192392 |
72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52361945 |
73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52173755 |
74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51605791 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51240749 |
76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51214545 |
77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50976809 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50440529 |
79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48892956 |
80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47496997 |
81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47484730 |
82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47152913 |
83 | Shigellosis_Homo sapiens_hsa05131 | 0.45218684 |
84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45128063 |
85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44856484 |
86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44733331 |
87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43886188 |
88 | Influenza A_Homo sapiens_hsa05164 | 0.43344640 |
89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42827919 |
90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40806540 |
91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40312742 |
92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39689203 |
93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39524870 |
94 | Apoptosis_Homo sapiens_hsa04210 | 0.37891309 |
95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37847409 |
96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37603347 |
97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37501960 |
98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37121787 |
99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37055003 |
100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37020700 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.36270953 |
102 | Phototransduction_Homo sapiens_hsa04744 | 0.36104318 |
103 | Pertussis_Homo sapiens_hsa05133 | 0.33119049 |
104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31877725 |
105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31776561 |
106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31287790 |
107 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.30665570 |
108 | Mineral absorption_Homo sapiens_hsa04978 | 0.30185086 |
109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29200991 |
110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28914441 |
111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28576779 |
112 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28448250 |
113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28213590 |
114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27175174 |
115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26449198 |
116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25118943 |
117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.24172484 |
118 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24058606 |
119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22990118 |
120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22981984 |
121 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22169461 |
122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21873399 |
123 | Malaria_Homo sapiens_hsa05144 | 0.21640419 |
124 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.21439140 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21054648 |
126 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19898194 |
127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19554388 |
128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19510230 |